Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | PTGFR | P43088 | 1/20 | 0.40 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.40 |
| ▸ | PDCD4 | Q53EL6 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6554483 | 0.81 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL6355736 | 0.72 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL1905959 | 0.71 | DAGLA (0.43) | DAGLAPDCD4 | |
| SCHEMBL8726836 | 0.71 | ALDH1A1 (0.70) | DAGLATBXA2RPTGFRPTGER2ALDH1A1 | |
| SCHEMBL4652808 | 0.71 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL22484690 | 0.70 | ALDH1A1 (0.52) | ALDH1A1 | |
| SCHEMBL22470028 | 0.70 | ALDH1A1 (0.52) | ALDH1A1 | |
| SCHEMBL4875958 | 0.70 | TBXA2R (0.39) | DAGLATBXA2RPTGFRPTGER2ALDH1A1 | |
| SCHEMBL25850990 | 0.70 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL16841232 | 0.69 | ALDH1A1 (0.61) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050026998-A1 | Compounds for the controlled release of active aldehydes | FIRMENICH SA (CH) | 2005-02-03 | — | — | US | claimed |
| EP-1487815-A1 | COMPOUNDS FOR THE CONTROLLED RELEASE OF ACTIVE ALDEHYDES | FIRMENICH SA (CH) | 2004-12-22 | — | — | EP | claimed |
| WO-2003082850-A1 | COMPOUNDS FOR THE CONTROLLED RELEASE OF ACTIVE ALDEHYDES | FIRMENICH SA (CH) | 2003-10-09 | — | — | WO | claimed |
| US-20050026998-A1 | Compounds for the controlled release of active aldehydes | FIRMENICH SA (CH) | 2005-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050026998-A1 | Compounds for the controlled release of active aldehydes | ALDH1A1, ADH5, ALDH16A1 | DAGLA 373/4885TBXA2R 1099/4885PTGFR 1371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.